Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis - Université de Reims Champagne-Ardenne Access content directly
Journal Articles Journal of Cystic Fibrosis Year : 2021

Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis

Philippe Reix
Aurélie Tatopoulos
  • Function : Author
Iulia Ioan
  • Function : Author
Muriel Le Bourgeois
  • Function : Author
Stéphanie Bui
  • Function : Author
Marie Luce Choukroun
  • Function : Author
Katia Bessaci-Kabouya
  • Function : Author
Pathologies Pulmonaires et Plasticité Cellulaire - UMR-S 1250
Michele Gerardin
  • Function : Author
Plamen Bokov
  • Function : Author
Jennifer da Silva
  • Function : Author
Jean-Louis Paillasseur
  • Function : Author
Pierre Regis Burgel
  • Function : Author

Domains

Life Sciences [q-bio]

valerian dormoy  : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03330701

Submitted on : Wednesday, September 1, 2021-10:47:50 AM

Last modification on : Thursday, October 14, 2021-1:10:15 PM

Not file

Dates and versions

hal-03330701 , version 1 (01-09-2021)

Identifiers

Cite

Philippe Reix, Aurélie Tatopoulos, Iulia Ioan, Muriel Le Bourgeois, Stéphanie Bui, et al.. Real-world assessment of LCI following lumacaftor-ivacaftor initiation in adolescents and adults with cystic fibrosis. Journal of Cystic Fibrosis, 2021, ⟨10.1016/j.jcf.2021.06.002⟩. ⟨hal-03330701⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

URCA P3CELL
14 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More